Home › Funds › WELCH & FORBES LLC › ABBV

WELCH & FORBES LLC position in ABBV

ABBVIE INC · Health Care

WELCH & FORBES LLC reported holding 342,782 shares of ABBV (ABBVIE INC) in its Q3 2026 13F filing — a position valued at US$89.7M, representing 1.07% of its reported portfolio and ranking #26 among its reported holdings. WELCH & FORBES LLC has disclosed ABBV holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)342.78K sh
Reported value held$89.67M
Portfolio Weight1.07%
First reportedQ3 2023
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How WELCH & FORBES LLC's ABBV position evolved

WELCH & FORBES LLC first disclosed a stake in ABBV in Q3 2023 at 395,066 shares (US$58.9M). The position peaked in Q3 2026 at 342,782 shares, worth US$89.7M. Across 13 filings, WELCH & FORBES LLC increased the stake 1 time(s), trimmed it 8 time(s) and left it unchanged 3 time(s). The most recent filing (Q3 2026) shows 342,782 shares valued at US$89.7M — a reduction of -3,196 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q3 2023 395.07K $58.89M New
Q4 2023 381.98K $59.19M Reduce
Q1 2024 371.78K $67.70M Reduce
Q2 2024 370.85K $62.36M Hold
Q3 2024 364.57K $72.00M Reduce
Q4 2024 363.55K $64.60M Hold
Q1 2025 354.62K $74.30M Reduce
Q2 2025 349.91K $64.95M Reduce
Q3 2025 348.37K $80.66M Hold
Q4 2025 345.95K $79.05M Reduce
Q1 2026 343.62K $74.73M Reduce
Q2 2026 345.98K $87.06M Add
Q3 2026 342.78K $89.67M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ABBV and 13F data

ABBV (ABBVIE INC) is a Health Care company. 31 other funds we track also report a position in ABBV — the largest reported positions include Vanguard Group (US$41.31B), BlackRock Inc (US$37.62B), VANGUARD CAPITAL MANAGEMENT LLC (US$30.26B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ABBV

All ABBV fund holders →

FAQ

How long has WELCH & FORBES LLC held ABBV?

WELCH & FORBES LLC has disclosed ABBV holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is WELCH & FORBES LLC's current position in ABBV?

As of Q3 2026, WELCH & FORBES LLC holds 342.78K shares of ABBV (ABBVIE INC), valued at $89.67M, representing 1.07% of its reported portfolio and ranking #26.

Has WELCH & FORBES LLC been buying or selling ABBV?

In the latest 13F filing (Q3 2026), WELCH & FORBES LLC reduced its position in ABBV. The position peaked in Q3 2026 at 342.78K shares.

Which other funds hold ABBV?

Other major institutional holders of ABBV include Vanguard Group, BlackRock Inc, VANGUARD CAPITAL MANAGEMENT LLC, among 31 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.